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 27 
Abstract:  28 
Desminopathies are a type of myofibrillar myopathy resulting from mutations in DES, 29 
encoding the intermediate filament protein desmin. They display heterogeneous 30 
phenotypes, suggesting environment influences. Patient muscle proteins show 31 
oxidative features linking oxidative stress, protein aggregation, and abnormal protein 32 
deposition. To improve understanding of redox balance in desminopathies, we further 33 
developed cellular models of four pathological mutants localized in 2B helical domain 34 
(the most important region for desmin polymerization) to explore desmin behavior 35 
upon oxidative stress. We show that the mutations desQ389P and desD399Y share 36 
common stress-induced aggregates, desR406W presents more scattered 37 
cytoplasmic aggregative pattern, and pretreatment with N-acetyl-L-cysteine (NAC), 38 
an antioxidant molecule, prevents all type of aggregation. Mutants desD399Y and 39 
desR406W had delayed oxidation kinetics following H2O2 stress prevented by N-40 
acetyl-L-cysteine pretreatment. Further, we used AAV-injected mouse models to 41 
confirm in vivo effects of N-acetyl-L-cysteine. AAV-desD399Y-injected muscles 42 
displayed similar physio-pathological characteristics as observed in patients. 43 
However, after 2 months of N-acetyl-L-cysteine treatment, they did not have reduced 44 
aggregates. Finally, in both models, stress induced some post-translational 45 
modifications changing Isoelectric Point, such as potential hyperphosphorylations, 46 
and/or molecular weight of human desmin by proteolysis. However, each mutant 47 
presented its own pattern that seemed to be post-aggregative. In conclusion, our 48 
results indicate that individual desmin mutations have unique pathological molecular 49 
mechanisms partly linked to alteration of redox homeostasis. Integrating these 50 
mutant-specific behaviors will be important when considering future therapeutics. 51 
52 
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Highlights 53 
►Desmin mutations trigger variable aggregative patterns and NAC pretreatment 54 
avoids it.  55 
►Desmin mutations induce delayed oxidation kinetic with H2O2 stress, which are 56 
prevented by NAC.  57 
►Stresses induce own post-aggregative post-translational modifications, which are 58 
prevented by NAC. 59 
►Distinct pathological molecular mechanisms of desmin mutations weigh on 60 
therapeutics. 61 
Keywords: desmin, oxidative stress, aggregation, N-acetyl-L-cysteine, myopathies, 62 
intermediate filaments. 63 
Introduction:  64 
Desmin is a muscle-specific type III intermediate filament (IF). All IFs share a 65 
common tripartite organization characterized by a central alpha-helical coiled coil-66 
forming region (rod-domain) and two non-alpha-helical regions (“head” and “tail”) with 67 
variable lengths and sequences (1) as represented for desmin in figure 1A. This 68 
structure allows protein monomers to assemble (2,3) and ultimately form networks 69 
within cells. Thus, desmin participates in cytoskeleton formation, crosslinking 70 
myofibrils and connecting them to mitochondria (4), nuclei, membrane desmosomal 71 
proteins in cardiac cells (2,3), or costamers in skeletal muscle (4,5).  72 
Currently, ~70 mutations within the human desmin gene, DES (HUGO Gene 73 
Nomenclature Committee database #2770), lead to desminopathies, a subcategory 74 
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of myofibrillar myopathies that mostly arise between the second and fifth decade of 75 
life (6,7). Individuals with desminopathies present skeletal or cardiac muscle defects 76 
(8) that exhibit heterogeneous features, such as progressive skeletal myopathy (9), 77 
different types of cardiomyopathy (10), or both (11–14). The same point mutation can 78 
produce different phenotypes within a family, suggesting that genetic factors as well 79 
as environmental (such as intensive sport practice, alimentation, anxiety…) influence 80 
disease progression (15).  81 
Most desmin mutations are missense and affect the 2B end of the protein rod central 82 
dimerization domain, leading to desmin network disorganization (16). The main 83 
histological characteristics are myofibrillar disorganization, sarcomere misalignment, 84 
and desmin-containing protein aggregates in the sarcoplasm. Many studies have 85 
investigated how desmin mutations affect the capacity of recombinant proteins to 86 
self-assemble in filaments in vitro, as well as in transient cell experiments with or 87 
without another IF (e.g., vimentin) (17). Indeed, several mutant monomers 88 
polymerize normally in vitro, while some present irregular-diameter filaments, such as 89 
desD399Y (17,18). For other mutants, the assembly process stops at intermediate 90 
steps, such as tetramer, unit-length filament, filament elongation, or IF maturation 91 
(17).  92 
Thus, desmin assembly and/or desmin aggregation seem to depend on sequence, 93 
without obvious links to mutation position. Moreover, some post-translational 94 
modifications (PTMs) of desmin or other IFs have been linked to 95 
assembly/disassembly (17). Modifications of PTMs pattern have also recently been 96 
highlighted in myofibrillar (19,20) or cardiac pathology (21) context. 97 
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In addition, mouse Des-/- muscle cell mitochondria exhibit an increase in size and 98 
number, loss of correct positioning, and pronounced degeneration after work 99 
overload (22,23). Further, desL345P transgenic (24) or desR349P knock-in (KI) mice 100 
also present mitochondria mislocalization or enzyme dysfunction (25). These 101 
alterations indicate a link between oxidative metabolism and desmin.  102 
Skeletal muscle fiber metabolism constantly generates reactive oxygen species 103 
(ROS) witch level depending to exercise intensity and regularity (26). Redox 104 
homeostasis continually neutralizes ROS with antioxidant protective molecules that 105 
belong to three main types: enzymes that can metabolize ROS and environmental 106 
oxygen peroxide (H2O2), endogenous non-enzymatic compounds, and exogenous 107 
non-enzymatic compounds (e.g., provided by food). Among endogenous 108 
antioxidants, glutathione appears to be most important in the context of muscular 109 
fatigue—the ratio between oxidized glutathione [disulfide glutathione (GSSG)] and 110 
reduced glutathione (GSH) is an indicator of redox status in cells or tissues (27). 111 
Among exogenous antioxidants, N-acetyl-L-cysteine (NAC) is known to counteract 112 
the increased levels of ROS and then to provide effects within muscle cells. In fact, 113 
this precursor of endogenous antioxidant, increases levels of the reduced glutathione 114 
before, during, and after exercise (28).  115 
Imbalanced redox homeostasis is a pathogenic mechanism and thus potential 116 
therapeutic target in myopathies. Indeed, SEPN1-related myopathy, RYR1-related 117 
myopathy, or Duchenne muscular dystrophy have direct defects in redox regulation 118 
systems or have secondary redox abnormalities (29). Previously, pretreatment with 119 
NAC before H2O2 exposure significantly improved cell survival in SelN‐devoid 120 
myoblasts, as well as in controls, whereas other food antioxidants did not (30). 121 
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Further, a link between oxidative stress and desmin protein aggregation has been 122 
shown in patient biopsies. Indeed, main glycoxidation marker (advanced glycation 123 
end product, N-carboxy-methyl-lysine, or N-carboxy-ethyl-lysine) levels are increased 124 
in muscle samples from individuals with desminopathies (31). Moreover, desmin is a 125 
major target of these oxidation and nitration modifications (32).  126 
As patient cells are rarely available, we previously constructed isogenic cell lines 127 
expressing inducible wildtype (desWT) or mutant desmin—with mutations located in 128 
the head, rod, and tail domains (desS46Y, desD399Y, and desS460I, respectively)—129 
to explore protein aggregation mechanisms. Only desD399Y is sensitive to stresses, 130 
such as heat shock or redox environmental changes (H2O2 or cadmium treatment). In 131 
addition, some antioxidant molecules, such as N-acetyl-L-cysteine (NAC) (33) and 132 
alpha-tocopherol (34), can prevent stress-induced aggregation.  133 
Here, we first further expanded our inducible cell lines to other 2B mutations. Indeed, 134 
mutations in the end of the 2B domain of desmin are predominant (~66%) in human 135 
patients with desminopathies and lead to musculoskeletal and cardiac phenotypes of 136 
variable severity (35). This area also contains a stutter region, a conserved sequence 137 
important for filament assembly and stabilization (36). Thus, the 2B region seems 138 
essential for polymerization of the desmin network, perhaps making it susceptible to 139 
stress. Moreover A357P, Q389P, and R406W mutations share with D399Y a 140 
common skeletal muscle phenotype in patients (distal and proximal myopathy). 141 
Patients also mainly present respiratory insufficiency (except for Q389P) and cardiac 142 
defects (except for A357P) (for review see 17). R406W leads to the most severe 143 
phenotype and presents particular subsarcolemmal desmin accumulation in skeletal 144 
muscle.  145 
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Mutations introducing proline in the C-terminal part of the 2B domain are the most 146 
frequent (12 out of 24) (35). They lead to desmin aggregation and affect cellular 147 
assembly of IFs (37). However, not all mutations are dominant—A360P is recessive 148 
(13). We chosed to study at least two mutations carrying a proline: A357P and 149 
Q389P. These two mutations present a phenotype, especially on skeletal muscles, in 150 
agreement with our model of myoblasts. In addition to these two mutations, R406W 151 
substitution affects the YRKLLEGEE region, another extremely conserved and 152 
important domain in the regulation of network assembly (38–40).  153 
Thus, we investigated whether the aggregative behaviors in stress conditions and the 154 
response to NAC pretreatment depend on the 2B location or on the specific mutation. 155 
Furthermore, we also analyzed the link between 2B mutations presenting stress 156 
induced aggregation and redox dynamics. To confirm the effect of NAC in a more 157 
physiological context, we performed experiments with injection of adeno-associated-158 
virus (AAV), expressing WT or mutated desmin, in mouse tibialis anterior (TA) 159 
muscle, with or without antioxidant treatment. Finally, to understand these behaviors, 160 
we analyzed post-translational modifications (PTMs) of desmin in cell or in muscle. 161 
Indeed, as described for other intermediate filaments, some PTMs, such as 162 
phosphorylation, ubiquitination, sumoylation, glycosylation, and/or ADP ribosylation, 163 
are known to modify their behavior (41). Thus, they could also regulate desmin in 164 
response to stress.  165 
Altogether, desmin cytoplasmic redox dynamic and PTMs alterations in our models 166 
provide new information on the variability and importance of oxidative redox balance 167 
in skeletal muscular cells containing a pathological variant of desmin.  168 
 169 
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Materials and methods: 170 
Molecular model and secondary structure predictions 171 
The crystal structure of human vimentin coil 2B fragment (CYS2) [residues 328 172 
(Cys328)–411; PDB entry 1GK4] was used to construct desmin 2B end domain 173 
models (WT and mutant) with PYMOL software (DeLano Scientific LLC, Palo Alto, 174 
CA, United States). For energy minimization, computations were done in vacuo with 175 
GROMOS96 43B1 parameters set, without reaction field, from Swiss-PdbViewer 176 
4.0.1 (http://spdbv.vitalit.ch/download.html). We used Pubmed Blast 177 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) for sequence alignment of CYS2 (residues 178 
328–411) and desmin (residues 333–416). 179 
Cell lines and culture 180 
New stable cell lines from murine C2C12 myoblasts (ATCC, NY, USA) were 181 
generated as previously described (33). Briefly, mutagenesis was performed on 182 
pPuro-Myc-human-Desmin vector to introduce human mutations desA357P, 183 
desQ389P, and desR406W, following manufacturer’s instructions (Quick Change-XL 184 
mutagenesis kit, Stratagene, San Diego, CA, United States). Plasmids were 185 
electroporated (Genepulser II, BioRad, Hercules,CA, United States; 500 µF, 350 V, 186 
with 10 µg of DNA) into clone 21 (tet-on) cells (33). Stable clones were selected after 187 
one week of puromycin selection. Doxycycline induction of human desmin variants 188 
was verified by western blotting (using c-Myc epitope antibody (1/1000, 9E10, Santa 189 
Cruz Biotechnologies, Dallas, TX, United States)) and immunostaining. Double stable 190 
cell lines were grown at 37°C and 5% CO2 in Dulbecco’s Modified Eagle’s medium 191 
(DMEM, Life Technologies, Carlsbad, CA, United States) supplemented with 20% 192 
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fetal calf serum (Eurobio, Les Ulis, France), 1% penicillin/streptomycin (Life 193 
Technologies, Carlsbad, CA, United States), 1 mg/mL G418 (Euromedex, 194 
Souffelweyersheim, France), and 2 μg/mL puromycin (Euromedex, 195 
Souffelweyersheim, France). 196 
Satellite cells were extracted from 2 gastrocnemius and 2 plantaris muscles of 1-197 
month-old C56Bl6(N) knock-in mice for the R405W mutation (murine homologue of 198 
human desmin R406W; named after KI-R405W) (12). Following previous work (42), 199 
muscles were incubated 4 x 10 min in a solution of DMEM-10 HamF12/Glutamax 200 
(Life Technologies, Carlsbad, CA, United States) containing 1.5 mg/mL of protease 201 
XIV (Sigma-Aldrich,  Saint-Louis, MO, United States) and 1/500 primocin (Invitrogen, 202 
Carlsbad, CA, United States) at 37°C under regular agitation. After each incubation, 203 
tubes were centrifuged at 400 g for 30 seconds at room temperature. Floating cells 204 
were eliminated, and 3 other fractions containing satellite cells were diluted in 20% 205 
FBS medium and sieved with a 40-µm filter. Filtrate containing satellite cells was 206 
centrifuged for 5 min at 1400 g at room temperature. Cells in DMEM-207 
HamF12/Glutamax containing 20% FBS, 2% Ultroser (Pall Life Sciences, 208 
Portsmouth, United Kingdom), 8.6 ng/mL of FGF2 (Life Technologies, Carlsbad, CA, 209 
United States), 1/100 N2 (Life Technologies, Carlsbad, CA, United States), and 210 
1/500 primocin were seeded onto 1/20 Matrigel-coated 6-well plates (Corning, 211 
Corning, NY, United States) at 1000 cells/well. After activation and proliferation, 212 
satellite cells were maintained or analyzed by seeding at 1000 cells/cm² on plastic 213 
covered with 1/20 Matrigel.  214 
Oxidative and heat stress procedures 215 
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As previously described, stable cell lines were seeded at 3 x 103 cells/cm2 in 6-well 216 
plates and induced with doxycycline (10 μg/mL, Sigma-Aldrich, Saint-Louis, MO, 217 
United States) after 24 h (28). Hydrogen peroxide and heat stresses were performed 218 
48 h after induction as follows: 0.2 mM H2O2 (Sigma-Aldrich, Saint-Louis, MO, United 219 
States) was added to the cell culture for 2 h or cells were heat shocked at 42°C for 2 220 
h. Cells were immediately analyzed (T0 time point) or media was replaced and cells 221 
were treated 24 h later (T24 time point). For pre-treatment, NAC (10 mM, #A7250 222 
Sigma-Aldrich, Saint-Louis, MO, United States) was added to cells 16 h before 223 
stress. 224 
Western blotting 225 
Myoblast proteins were extracted by scraping cells in RIPA buffer without SDS [50 226 
mM Tris pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% NP40, 1 mM Na3VO4, 10 mM NaF, 227 
1 mM PMSF, protease inhibitor cocktail 1X (complete mini, EDTA free, Roche, Bâle, 228 
Switzerland)] for 1D SDS-PAGE or urea buffer (8 M urea, 2 M thiourea, 4% CHAPS, 229 
50 mM DTT) for 2D SDS-PAGE. After migration, proteins were transferred to 230 
nitrocellulose membranes (0.45 µm, Macherey Nagel, Düren, Germany), which were 231 
saturated with 5% non-fat milk in 0.5% Tween/PBS. Membranes were incubated with 232 
the primary antibody at the appropriate dilution for 1 h at room temperature or 16 h at 233 
4°C. Primary antibodies used were: 1- mouse monoclonal anti-c-Myc (1/1000, 9E10, 234 
Santa Cruz Biotechnologies, Dallas, TX, United States); 2- rabbit polyclonal anti-235 
desmin (1/1000, # C3956, Sigma-Aldrich, Saint-Louis, MO, United States); 3- mouse 236 
monoclonal anti-alpha-actin (1/2000, #MAB1501R, Millipore, Burlington, MA, United 237 
States); or 4- rabbit polyclonal anti-GFP (1/2500, A11122, Life Technologies, 238 
Carlsbad, CA, United States). Isotype-specific anti-mouse or anti-rabbit secondary 239 
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antibody coupled with horseradish peroxidase (1/10000, #31430 or #31460, Pierce, 240 
Thermo Scientific, Waltham, MA, United States) was detected by incubating with 241 
Clarity Western ECL (BioRad, Hercules, CA, United States) and visualized with a 242 
CCD camera (FUJI Las 4000 or Ai600, GE Healthcare, Chicago, IL, United States). 243 
Cell immunofluorescence 244 
Cells were fixed with 2% paraformaldehyde (Santa Cruz Biotechnologies, Dallas, TX, 245 
United States) for 15 min at room temperature, permeabilized 5 min with 0.5% Triton 246 
X-100, and incubated with mouse monoclonal anti-c-Myc primary antibody (1/100, 247 
9E10 #sc40 Santa Cruz, Biotechnologies, Dallas, TX, United States) for 1 h at room 248 
temperature. After 3 washes with PBS, cells were incubated 45 min with isotype-249 
specific anti-mouse secondary antibody labeled with Alexa-488 (#A11001, Molecular 250 
Probes, Eugene, OR, United States). DNA was stained with Hoechst 33258 (1 251 
µg/mL, Sigma-Aldrich, Saint-Louis, MO, United States) for 10 min. Finally, cells were 252 
washed in PBS and mounted in Fluoromount medium (Interchim, San Diego, CA, 253 
United States). Images were acquired with confocal microscopy (LSM700 Zeiss, 254 
Iena, Germany) at the imaging facility of the Functional and Adaptive Biology (BFA) 255 
unit. 256 
For aggregation measurements, images were taken as 5x5 tile scans on 3 random 257 
nuclear fields chosen in Hoechst-stained areas. Total cell number was calculated by 258 
counting nuclei with an ImageJ software in-house macro. Cells with aggregates were 259 
visually counted on the images. Aggregation percentage and ratio between stressed 260 
versus unstressed aggregated cells were calculated. Experiment was repeated at 261 
least 3 times. 262 
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Redox dynamics 263 
Mammalian cell vector expressing cytoplasm-targeted HyPer (cyto-HyPer) was 264 
constructed by amplifying HyPer sequence (Evrogen, Moscow, Russia, (43)) and 265 
introducing a Nuclear Export Signal (NES). The PCR product, fusing NES in frame to 266 
the 3’ end of HyPer, was then cloned in pCMV/myc/cyto vector (Life Technologies, 267 
Carlsbad, CA, United States). Vector expressing cytoplasm-targeted Grx1-roGFP2 268 
(cyto-Grx1-roGFP2) was constructed in a similar way using pEIGW-Grx1-roGFP2 269 
(Addgene, Cambridge, MA, United States (44)) as template. Expression vector 270 
encoding HyPer targeted to mitochondrial matrix (mito-HyPer) was purchased from 271 
Evrogen (Moscow, Russia). Stable cell lines or satellite cells were seeded at 11,500 272 
cells/cm2 or 22,000 cells/cm2, respectively, in 6-well plates. After 24 h, cells were 273 
transfected with cyto-HyPer, mito-HyPer, or cyto-Grx1-roGFP2 in DMEM medium 274 
without antibiotics using JetPRIME (Polyplus-transfection, Illkirch-Graffenstaden, 275 
France) according to manufacturer’s instructions. Eight hours after transfection, 276 
antibiotics were added, including doxycycline for desmin induction. Transfection 277 
efficiency was evaluated on an inverted fluorescence microscope with a FITC filter 278 
(Zeiss, Iena, Germany) at the imaging facility of the BFA unit. 279 
Oxidative kinetics were started by adding 0.1 mM H2O2 to cells in complete media 280 
and incubating for 5, 15, 30, 60, or 120 min. Medium was aspirated and cells were 281 
washed with PBS and then overlaid with 15% trichloroacetic acid. After 30 min, cells 282 
were scraped and pelleted in 1.5-mL microtubes. After two washes with ice-cold 283 
acetone and air drying, pellets were resuspended in TES buffer (100 mM Tris pH 8.8, 284 
10 mM EDTA, 1% SDS). Loading buffer without reducing agent was added to 285 
samples. Equal volumes were loaded on 12% SDS acrylamide gels and results were 286 
analyzed by western blotting. 287 
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Intramuscular injection of AAV vectors  288 
Plasmids encoding c-Myc-tagged human desmin (desWT and desD399Y) under the 289 
regulation of the CMV promoter were used to prepare AAV vectors. 290 
AAV2/2.CMV.Myc-desWT (AAV-desWT) or Myc-desD399Y (AAV-desD399Y) were 291 
provided by the Vector Production Center of the Therapeutic Research Institute at 292 
the Health Research Institute of the University of Nantes (UMR1089, Nantes, 293 
France). Final viral preparations were split in 50-μL aliquots in D-PBS (with Ca2+ and 294 
Mg2+) and stored at −80°C. Number of viral genomes (vg) was titrated by polyA 295 
quantitative PCR and was 5.2 x 1012.mL-1 for AAV-desWT and 5 x 1012.mL-1 for AAV-296 
desD399Y.  297 
The injection procedure was previously described by Joanne et al. (45) Briefly, for 298 
intramuscular injections, 11 week-old male C57BL/6J mice (Janvier Labs, Le Genest-299 
Saint-Isle, France) were anesthetized by intraperitoneal injection of an analgesic and 300 
sedative drug mix [100 mg.kg-1 ketamine (Merial, Lyon, France) and 10 mg/kg 301 
xylazine (Bayer, Leverkusen, Germany)]. Each TA muscle was injected with 70 μL of 302 
AAV diluted in PBS (~3 x 1011 vg/70 μL) using an insulin syringe. Animals were split 303 
into 4 groups of n=5 mice: AAV-desWT with NAC, AAV-desWT without NAC, AAV-304 
desD399Y with NAC, and AAV-desD399Y without NAC. NAC was diluted to 20 mM 305 
in drinking water. Bottles were changed every 2–3 days and weighed before and 306 
after replacement to calculate the absorption volume of NAC by mice. 307 
Animal experiments were conducted with respect to animal health and well-being, 308 
and all procedures were approved by our institutional ethics committee (authorization 309 
APAFIS#5441 -20 16052314036983 v7, for AAV-injected mice; CEB-16-2016, for KI-310 
R405 mice). All procedures were also conducted according to French and European 311 
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laws, directives, and regulations on animal care (European Commission Directive 312 
86/609/EEC; APAFIS#5441 -20 16052314036983 v7). For AAV experiments, the 313 
animal facility (Centre d’expérimentation Fonctionnelle (CEF), Pitié Salpétrière 314 
Hospital, Paris) is fully licensed by French competent authorities and has animal 315 
welfare insurance. 316 
Preparation of TA muscles  317 
TA muscles were removed 1 or 2 months following injection after euthanizing mice by 318 
cervical dislocation. For immunohistochemical analysis, muscles were embedded in 319 
tragacanth gum (Fisher Scientific, Hampton, NH, United States) and frozen by 320 
plunging in isopentane precooled in liquid nitrogen for at least 1 minute. For western 321 
blotting, muscles were directly frozen in liquid nitrogen in microtubes and later 322 
pulverized in a cryogenic mortar (Dutscher, Issy-les-Moulineaux, France) and 323 
resuspended in urea buffer for 2D gels. 324 
Muscle sections and histological staining  325 
Serial sections of 6 μm thickness were sliced using a CM1950 cryostat, (Leica, 326 
Wetzlar, Germany) recovered on Superfrost Plus microscope slides (Thermo 327 
Scientific, Waltham, MA, United States), and stored at –80°C. Muscle sections were 328 
kept at room temperature for 20 min before staining with either hematoxylin/eosin 329 
(HE), succinate dehydrogenase (SDH), or fluorescent antibodies as follows. 330 
HE: Transverse muscle sections were incubated with 0.7% hematoxylin solution 331 
(Harris modified, Sigma-Aldrich, Saint-Louis, MO, United States) for 6 min at room 332 
temperature, washed 5X with water, and stained with 0.5% eosin in acidified 90% 333 
ethanol (Sigma-Aldrich, Saint-Louis, MO, United States) for 1 min at room 334 
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temperature. Muscle sections were dehydrated by incubating in successive baths of 335 
gradually increasing ethanol concentrations (30%, 50%, 70%, 85%, 95%, and 100%, 336 
repeated twice) for 2 min each, followed by two baths in clearing solution (Histo-337 
Clear, National Diagnostics, Atlanta, GA, United States) for 10 min and 15 min, and 338 
rapidly mounted in VectaMount medium (Clinisciences, Nanterre, France). Images 339 
were acquired on a stereomicroscope (Leica, Wetzlar, Germany) at the BFA unit. 340 
SDH: Transverse muscle sections were stained by immersion in SDH buffer (0.2 M 341 
phosphate buffer containing 5.4% sodium succinate and 0.1% nitro blue tetrazolium) 342 
for 2 h at 37°C and then washed with water. Finally, muscle sections were either 343 
mounted directly in VectaMount medium (Clinisciences, Nanterre, France) or 344 
processed for further immunofluorescence. Images were captured on a 345 
stereomicroscope (Leica, Wetzlar, Germany) at the BFA unit. 346 
Immunostaining: Warmed muscle sections were fixed with 4% paraformaldehyde for 347 
10 min at room temperature. Endogenous fluorescence was prevented with 50 mM 348 
NH4Cl for 30 min. Sections were permeabilized in 0.5% triton/PBS for 10 min, 349 
blocked in 1% bovine serum albumin/PBS, and incubated with rabbit anti-Myc 350 
(1/1000, # C3956, Sigma-Aldrich, Saint-Louis, MO, United States) or rabbit anti-351 
laminin (1/100, #L9393, Sigma-Aldrich, Saint-Louis, MO, United States) primary 352 
antibodies for 1 h at room temperature or overnight at 4°C. Primary antibodies were 353 
detected by incubating sections with suitable secondary antibodies for 45 min.  354 
DNA was stained with 1 µg.mL-1 Hoechst 33258 (Sigma-Aldrich, Saint-Louis, MO, 355 
United States) for 10 min. Cells were washed in PBS and mounted in Fluoromount 356 
medium (Interchim, San Diego, CA, United States). All images were captured using a 357 
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digital camera mounted to a confocal laser scanning microscope (LSM700 Zeiss, 358 
Iena, Germany) at the imaging facility of the BFA unit.  359 
Analysis of TA muscle characteristics  360 
TA fiber amount and diameter (minimum Feret values) were calculated on whole 361 
muscle transverse sections stained with laminin. Images were analyzed with ImageJ 362 
software. Percent transduction was calculated by measuring the number of fibers that 363 
were positively stained for Myc compared to the total number of fibers in the section. 364 
For aggregation rate, number of fibers containing aggregates was reported in relation 365 
to total transduced fibers. 366 
2D gel electrophoresis 367 
2D gel electrophoresis was performed at the proteomics platform at the Cochin 368 
Institute (Paris, France). Briefly, protein separation was performed by 369 
isoelectrofocusing on 7-cm pH 4–7 strips in the first dimension and SDS-PAGE on 10 370 
or 12% polyacrylamide gels in the second dimension. Proteins were transferred to 371 
nitrocellulose membranes and analyzed by western blotting. Calculation of theoretical 372 
isoelectric points (pI) for Myc-labeled desWT and mutant desmin proteins provided 373 
different values according to the website used (Table 1).  374 
375 
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 376 
Isoelectric point 
(pI) calculation 
ExPASy 
Protein 
Calculator 
v3.4 
Protein 
isoelectric 
point 
calculator 
Scansite 
WT murine 
desmin 
5.21 5.28 5.05 5.21 
WT human 
desmin 
5.21 5.28 5.06 5.21 
WT  
Myc-desmin 
5.11 5.17 5.07 5.11 
D399Y  
Myc-desmin 
5.15 5.20 5.03 5.15 
 377 
Table 1: Algorithmic isoelectric point (pI) calculations from different web sites:  378 
ExPASy (https://web.expasy.org/compute_pi); Protein Calculator v3.4 (http://protcalc.sourceforge.net);  379 
Protein isoelectric point calculator (http://isoelectric.org);  380 
Scansite (https://scansite4.mit.edu/4.0/#calcMolWeight). 381 
 382 
One site also indicates phosphorylated peptide molecular weights and 383 
phosphorylation that regulate desmin network assembly. For tagged desWT, the 384 
obtained values are detailed in Table 2. 385 
Phosphates 0 1 2 3 4 5 6 7 8 
Molecular 
weight (kD) 
54.7 54.8 54.9 54.9 55.0 55.1 55.2 55.3 55.3 
Isoelectric 
point 
5.11 5.07 5.04 5.00 4.97 4.94 4.91 4.88 4.85 
Table 2: Predictions of molecular weight evolutions and isoelectric points according to the number of 386 
phosphorylation of desWT (https://scansite4.mit.edu/4.0/#calcMolWeight). 387 
Statistical analysis 388 
Box plots were created with GraphPadPrism software or R free software, and results 389 
were statistically analyzed with non-parametric tests—“nparcomp” function with 390 
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Dunnet comparison to WT, or Tukey comparison for others. Curves, scatter plots, 391 
and histograms as well as corresponding graphic analyses were done with 392 
GraphPadPrism software—either 2-way ANOVA corrected by Bonferroni non-393 
parametric function, or Kruskall-Wallis tests. Significant differences were considered 394 
at p < 0.05. 395 
Results: 396 
DesA357P, desQ389P, desD399Y, and desR406W mutants located in the 2B 397 
desmin rod domain exhibit in silico distinctive structural interactions.  398 
DesD399Y is located distally in the 2B desmin rod domain. We previously 399 
demonstrated that it exhibits stress-induced aggregation, whereas mutations located 400 
in the head (desS46Y) or tail (desS460I) do not display this aggregation (33). To 401 
further investigate mechanisms leading to stress-induced aggregation, we chose 402 
three other pathological mutations—desA357P, desQ389P, and desR406W (Figure 403 
1A)—also located in the end of this domain between stutter and C-terminal regions, 404 
which is a notorious mutation hot spot (35).  405 
First, we constructed desmin 2B end domain mutant and WT models with PYMOL 406 
software and compared in silico the impact of each substitution (Figure 1B). A357P is 407 
located in the stutter region that is considered critically important for proper filament 408 
assembly. Further, it is in the "e" position in the heptad (internal residue repeats 409 
conserved in IF, as described by Strelkov et al.(46). On our structural representation, 410 
it is well inside the dimer and phenylalanine lateral chains face in both directions. We 411 
can see the position of alanine in the helix/dimer and its replacement with proline. 412 
Representation of structural modifications occurring with Q389P substitution shows 413 
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loss of a large negative side chain residue and gain of a small neutral one. D399Y 414 
and R406W substitutions provide insight about ionic bridging over two disrupted 415 
domains—in both, ionic residues are replaced with aromatic amino acids.  416 
 417 
 418 
Figure 1: Mutation locations within desmin structure and in silico modeling of mutation effects on 419 
structure of desmin coiled coil 2B domain. (A) Overview of desmin structure showing locations of 420 
individual mutations in the 2B domain and myc tag. (B) Graphic representation of tripartite desmin, 421 
based on vimentin crystal structure (1gk4), with mutations in central rod 2B domain of each monomer, 422 
with amino acids of interest represented by molecular structures. WT helical regions are magenta and 423 
mutants are cyan or green. A357P and Q389P mutations are dark blue. A357P is located in the stutter 424 
region, so conserved phenylalanine is also in molecular structure. D399 and R406 interactions (salt-425 
bridge) with side chain residue K395 or E401 are in dark blue and are represented with dotted lines. 426 
New stable cell lines expressing desmin mutations exhibit the same expression 427 
level as desD399Y-expressing cells.  428 
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Second, we generated six new inducible stable cell lines (2 clones per mutation) 429 
expressing desA357P, desQ389P, and desR406W according to the same protocol 430 
that we used for desD399Y and desWT (25). Expression in all clones was analyzed 431 
by western blot to confirm the level of exogenous human desmin compared to 432 
desD399Y (Figure 2).  433 
 434 
Figure 2: Steady-state desmin expression levels. Western blot of endogenous and human Myc-435 
desmin in inducible stable cell lines 72 h after induction (T24 without stress). Actin represents a 436 
loading control. “Cl-X” represents name of the selected clone for each desmin mutation.  437 
For each mutation, one construct expressed low levels of desmin and another 438 
expressed higher levels. At steady state, endogenous desmin was always more 439 
highly expressed than exogenous protein (maximum ratio exogenous/endogenous of 440 
1:1 for desWT clone 29 and 0.8:1 for des D399Y clone 26; Table 3). Overall, clones 441 
had a similar ratio of ~0.4:1, permitting us to compare new inducible clones to each 442 
other in basal conditions or upon stress. Moreover, as demonstrated in table 3, the 443 
basal protein aggregation in these cells remained below 3.5% (Table 3). 444 
445 
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 446 
Clone 
Desmin expression ratio 
(exogenous/endogenous) 
Basal aggregation (%) 
desWT-Cl-16 0.4 
0.6 
desWT-Cl-29 1.0 
desD399Y-Cl-26 0.8 2.9 
desD399Y-Cl-33 0.8 2.1 
desA357P-Cl-20 0.1 
0.5 
desA357P-Cl-21 0.3 
desR406W-Cl-1 0.5 1.4 
desR406W-Cl-13 0.4 3.5 
desQ389P-Cl-G 0.2 2.0 
desQ389P-Cl-L 0.3 3.0 
 447 
Table 3: Steady-state desmin expression levels and aggregation percentages. Western blot 448 
analysis of endogenous and human Myc-desmin in inducible stable cell lines 72 h (T24) after 449 
induction. Quantification was realized with ImageJ software. Protein amounts were normalized with 450 
anti-alpha-actin antibody (Actin). Basal aggregation percentage was calculated as described in 451 
material and methods. 452 
Stresses induce protein aggregation only in desQ389P, desD399Y, and 453 
desR406W, with varying aggregate morphologies. 454 
We measured desmin aggregation in all stable cell lines in response to oxidative or 455 
heat shock stresses after 24h. In response to stress, a normal desmin network was 456 
present in desWT- or desA357P-expressing cell lines (Figure 3A, first row).  457 
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 458 
Figure 3: Increased aggregation upon stresses in desD399Y, desQ389P, and R406W cells, but 459 
not desA357P cells. (A) Representative confocal micrographs showing immunostaining at 24 h after 460 
oxidative stress (T24) for Myc-desmin (green) and Hoechst dye (blue). DesWT and desA357P form 461 
normal networks. DesQ389- and desD399Y-expressing cells form large aggregates near the nucleus 462 
(arrows, left and middle panels). DesR406W-expressing cells form smaller accumulations distributed 463 
throughout the cytoplasm (arrows, right panel). White bar = 20 μm, 40x magnification. (B) Box plot 464 
representing the aggregation percentages 24 h after stress (T24) compared to untreated cells. Three 465 
different treatments are shown: heat shock (HS), oxidative stress (H2O2), and no stress (NT). Cells 466 
were counted in at least 3 independent experiments (>100 cells each) (ns: not significant; *p < 0.05, 467 
compared to unstressed).  468 
 23 
 
As previously described, stress of desD399Y-expressing cells induced large 469 
aggregates very close to the nucleus (Figure 3A, middle in second row). DesQ389P 470 
displayed similar characteristics (Figure 3A, left in second row). DesR406W also 471 
exhibited stress-induced, variably-shaped aggregates, although they had weaker 472 
staining, maybe due to small size. These aggregates were also more numerous and 473 
more dispersed in the cytoplasm (Figure 3A, right in second row). We quantified 474 
aggregation rates for each stable clone, representing cells with any aggregates, as 475 
compared to the total cell population (Figure 3B, Supp. Data 1). DesA357P-476 
expressing cells presented the same pattern as desWT, with no modification of 477 
aggregation rate, indicating that desA357P cells are not sensitive to oxidative or heat 478 
shock stress. In contrast, heat shock significantly induced a high aggregation rate for 479 
desQ389P and desD399Y (~20–40-fold increase), while oxidative stress led to 480 
significant, but less, aggregation (~10-fold increase). DesR406W cells also had 481 
significant aggregation in response to stress, although with more dispersed values. 482 
The anti-aggregative effect of NAC in the oxidative condition was confirmed for 483 
desQ389P, desD399Y, and desR406W (Figure 4). Indeed, ratios of aggregate 484 
percentages comparing NAC-treated and untreated cells showed a noticeable 485 
decrease. For all cell lines sensitive to oxidative stress, NAC pretreatment 486 
significantly reduced stress-induced aggregation. 487 
 24 
 
 488 
Figure 4: Effect of NAC as an anti-aggregative molecule on stable cell lines expressing 489 
desQ389P, desD399Y, and desR406W. First, aggregate-containing cells were quantified, untreated 490 
or pretreated with NAC, 24 h after stress or control conditions (NT). Then, box plots represent the ratio 491 
of percentage of cells with aggregates in the presence of NAC, reported to untreated cells. Cell 492 
counting was performed on three independent experiments (~100 cells each). For each clone, 493 
compared to its control NT, *p < 0.05, as calculated with Kruskall-Wallis non-parametric test.  494 
Cytoplasmic redox dynamic in desmin mutant cell lines exhibits various 495 
behaviors. 496 
To further investigate how stress induces aggregation in all responsive cell lines and 497 
how NAC can prevent this effect, specific redox reporters were used to monitor redox 498 
balance in cells expressing desmin mutants following oxidative stress. We first used 499 
the cyto-Grx1-roGFP2 to monitor cytoplasmic redox dynamic. This reporter 500 
specifically reacts with GSSG/GSH in the targeted compartment, so the percentage 501 
of the oxidized form reflects the redox state of glutathione (44) (Figure 5A and 5B). A 502 
second probe, HyPer, reacts specifically with H2O2 and is targeted to the cytoplasm 503 
(cyto-HyPer). Therefore, the percentage of the oxidized form of cyto-HyPer reflects 504 
the quantity of cytoplasmic H2O2 over time (Figure 5C and 5D). 505 
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 506 
Figure 5: desD399Y and desR406W trigger alteration of redox balance during stress.  507 
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(A) Representative western blots of the oxidized and reduced forms of cyto-Grx1-roGFP2 reporter 508 
following oxidative stress in stable cell lines expressing desWT or desD399Y (B) Quantification of 509 
oxidation kinetics of the cyto-Grx1-roGFP reporter over time. (C) Representative western blots of the 510 
oxidized and reduced forms of cyto-HyPer reporter following oxidative stress in stable cell lines 511 
expressing desWT or desD399Y with the cyto-HyPer reporter. (D) Quantification of oxidation kinetics 512 
of the cyto-HyPer reporter over time. (E) Percentage of oxidized cyto-HyPer in stable cell lines 513 
expressing desWT, desD399Y, desQ389P, or desR406W, without pretreatment. (F) Percentage of 514 
oxidized cyto-HyPer in satellite cells from KI-R405W mice. (G) Percentage of oxidized cyto-HyPer in 515 
stable cell lines expressing desWT or desD399Y after NAC pretreatment (10 mM). (H) Percentage of 516 
oxidized mito-HyPer in stable cell lines expressing desWT, desD399Y, desQ389P, or desR406W, 517 
without pretreatment. Each point represents the mean of three independent experiments, with bars 518 
indicating SEM. Prism software was used for 2-way ANOVA, corrected by Bonferroni non-parametric 519 
function (*p < 0.05; **p < 0.01; ***p < 0.001). 520 
Both cyto-Grx1-roGFP2 and cyto-HyPer probes were first compared in experiments 521 
with desWT and desD399Y clones. There were no significant differences in cells 522 
expressing desWT or desD399Y with Cyto-Grx1-roGFP (Figure 5B). Using cyto-523 
HyPer, however, we detected significantly delayed oxidation kinetics in the cytoplasm 524 
of desD399Y clones (Figure 5D). Indeed, more H2O2 remained in desD399Y clones 525 
at 60 min after the beginning of oxidative stress compared to desWT clones, 526 
although both constructs reached near-zero values after 120 min.  527 
We thus expanded cyto-HyPer probes analysis to the two other mutants with stress-528 
induced aggregation, desR406W and desQ389P. Similar to desD399Y, both clones 529 
expressing desR406W had similar significant differences in reporter oxidation 530 
depending on the duration of oxidative stress (Figure 5E). We confirmed these 531 
results using the more physiological model of satellite cells extracted from our new 532 
KI-R405W animal model. These cells showed very comparable delayed recovery of 533 
basal reporter reduction (Figure 5F). In contrast, unexpectedly considering the 534 
aggregative pattern seen in Figure 3A, desQ389P cell lines have a similar behavior 535 
to desWT (Figure 5E).  536 
To better understand the effect of NAC pretreatment on the evolution of cytoplasmic 537 
content during H2O2 incubation, we made the same measurements in the presence 538 
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of NAC. NAC especially reduced the percentage of oxidized reporter in cells 539 
expressing desD399Y (Figure 5G). Differences in the averages between untreated 540 
and treated showed that this decrease was ~16%–25% for both.  541 
Finally, we investigated the mitochondrial effect of H2O2 incubation using the 542 
mitochondrial matrix-targeted HyPer reporter. Redox balance is distinct in this 543 
organelle, as the reporter was more oxidized even without treatment and remained 544 
unchanged in all experiment conditions (Figure 5H). This indicates that mitochondria 545 
are not affected as cytoplasm in response to oxidation.  546 
Expression of desD399Y in vivo induces aggregation with slightly altered SDH 547 
repartition in adult mouse muscle fibers. 548 
Heat-shock and oxidative stress are two types of environmental variations that can 549 
be found in muscle physiology (47). DesD399Y induces aggregation following these 550 
environmental stresses, as do other mutations, such as desQ389P or desR406W. 551 
We used a specific desD399Y mouse model with AAV-injected TA muscle to confirm 552 
the anti-aggregative effect of NAC in vivo. We initially injected AAV containing 553 
desWT or desD399Y in TA muscle of C57BL/6J mice and then analyzed resulting 554 
desmin expression and aggregation with or without NAC treatment after 1–2 months. 555 
We calculated transduction efficiency by counting anti-Myc-stained fibers compared 556 
to all fibers stained with laminin (Figure 6A and B). Surprisingly, transduction 557 
efficiency was variable and higher for desWT (mean: 75%) than desD399Y (~50%), 558 
regardless of the duration before analysis (1 or 2 months).  559 
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 560 
Figure 6: AAV-injected muscles overexpressing desD399Y mimic some important features of 561 
human desminopathies: an in vivo model to test the effect of NAC as a putative anti-562 
aggregative molecule. (A) Representative images of immunohistochemical staining of muscle cross-563 
sections with anti-Myc antibodies to visualize transduced fibers (left) and laminin to visualize all fibers 564 
(right). Results are quantified in plots of (B) transduction percentage and (C) aggregation percentage 565 
from 4 injected mouse TA muscles for each condition. (D) Confocal micrographs of transversal (left) 566 
and longitudinal (middle) sections of muscle expressing desWT or desD399Y stained with anti-Myc 567 
antibodies (green). Nuclei are counterstained with Hoechst dye (blue). Right panels show HE-stained 568 
transverse sections imaged with a stereomicroscope. White arrows indicate aggregates. Images taken 569 
with a 40x objective; white bar = 25 µm. (E) Confocal micrographs of a series of desD399Y-injected 570 
muscle cross-sections stained with anti-Myc antibodies (green) and Hoechst dye (blue) (left and right 571 
panels) or SDH (middle panel). Circles highlight area with aggregation and the absence of SDH 572 
staining. Images taken with a 40x objective.  573 
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As expected, expression of ectopic desmin was detected in muscle protein extracts 574 
after western blotting with anti-Myc or anti-desmin antibodies (Supp. Data 2). 575 
Aggregation percentages were evaluated by counting fibers with aggregates, 576 
regardless of the number of aggregates, compared to all fibers (Figure 6C). In AAV-577 
desWT-injected TA, <5% of fibers presented aggregates, while ~95% of AAV-578 
desD399Y-injected fibers were positive for aggregates. As observed in stable cell 579 
lines, aggregates were always localized around nuclei (Figure 6D). Disorganization of 580 
surrounding z-disks, as observed in patient biopsies with aggregates, was not noted. 581 
In a few cases, fibers with aggregates had some areas without SDH staining (in 582 
circles in Figure 6E). Those small spots indicated absence of enzyme activity and 583 
were smaller than rubbed-out fibers observed in patient biopsies (i.e. where, in some 584 
muscle fibers, SDH stain looks as though it has been rubbed away inside the fiber). 585 
In addition, we quantified fiber size in injected muscles. Minimum Feret diameters 586 
(min Feret) is commonly considered a better marker than area measurement for 587 
muscle physiology comparisons, because it minimizes the effects of oblique 588 
sectioning. AAV-desD399Y-injected muscles have slightly decreased min Feret 589 
diameter of fibers compared to AAV-desWT-injected muscles (Supp. Data 3). 590 
Altogether, data indicate that AAV-desD399Y injected muscle mimics some main 591 
human desminopathy features and could serve as a model to test the antioxidative 592 
effects of NAC. 593 
 594 
The day following injection, we split mice into two groups: one with untreated drinking 595 
water, and one with 20 mM of NAC solution in the drinking water. Despite results with 596 
cell lines expressing desD399Y, aggregation was similar with or without NAC 597 
treatment (Figure 6C). However, unexpectedly and independently of the desD399Y 598 
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mutant, NAC treatment increased the total number of fibers (Supp. Data 3A) and 599 
seemed to be associated with a slight decrease in min Feret diameter (Supp. Data 600 
3B).  601 
2B desmin mutants exhibit different PTM patterns in vitro and in vivo. 602 
To understand some molecular alterations of desminopathies upon stress, we 603 
investigated PTMs in our cell and mouse models of pathological mutations under 604 
different environmental factors. We hypothesized that PTM differences can be linked 605 
to stress-induced aggregation, as highlighted previously. We thus used bidirectional 606 
gels to look for differences between exogenous desmin PTMs in stable clones 607 
expressing desWT versus mutants 24 h after heat shock or oxidative stress, or in 608 
injected muscles. 609 
As expected, human Myc-tagged desmin presented a pI of ~5.2 (coherent with Table 610 
1). However, we observed several patterns. Untreated desWT cells (clone 29) had 611 
four spots, whereas heat-shocked cells had at least eight spots with the same 612 
molecular weight (Figure 7, first line, two first columns). DesD399Y cells showed the 613 
same pattern, although they presented several additional spots with higher molecular 614 
weights (Figure 7, second line, two first columns). We found similar results after 615 
oxidative stress by H2O2 (Figure 7, fourth column), although treated desWT-616 
expressing clones did not have as many spots as expected (Figure 7, WT/H2O2 T24).  617 
618 
Figure 7: Stress induces various desmin PTMs, depending on the mutation. For cell models 619 
(left): 2D-PAGE analysis of total protein extracts from stable clones expressing desWT (WT-Cl29) or 620 
mutant desD399Y (D399Y-Cl26), desQ389P (Q389P-Cl-L), or desR406W (R406W Cl-1) or satellite 621 
cells from KI-R405W mice. Samples represent different time points (T0, just after stress; T24, 24 h 622 
after stress) and stresses [thermal, HS, or oxidative (H2O2)] with or without NAC pretreatment. For 623 
muscles (right): 2D-PAGE analysis of total protein extracts of TA muscles, either AAV-injected (with 624 
desWT or desD399Y), treated with NAC for 2 months or untreated, or from KI-R405W mice. 625 
After exposure to heat shock or oxidative stress, extracts from the stable clone 626 
expressing desQ389P presented two forms of desmin with close molecular weights 627 
(Figure 7, third line). One is the expected size of desmin (53 kDa) with several 628 
additional spots that could represent desD399Y, and the second is close to 49 kDa. 629 
The day after oxidative stress, desR406W also had a different migration profile from 630 
desWT. We observed four spots, with some additional lower-molecular-weight spots 631 
close to 49 kDa, similar to Q389P but with a higher pI (~5.4).  632 
Because aggregates are already present 24 h after stress, we wanted to determine 633 
whether the observed PTMs take place just after the stress, when no aggregation is 634 
detectable. For all analyzed cell lines, desmin patterns at T0 were the same as for 635 
untreated cells (four spots) (Figure 7, third column). We also examined the patterns 636 
at T4h, when aggregation begins for the three previously studied cell lines (33). 637 
Profiles were similar to those obtained at T0—four spots of different pIs but similar 638 
molecular weights (data not shown). Thus, these results suggest that PTMs are 639 
probably a post-aggregative process. 640 
We also analyzed desmin patterns by 2D-PAGE after stressing cells that were 641 
pretreated with NAC. Except for desR406W, all mutant patterns in the presence of 642 
NAC were similar to desWT without stress (Figure 7, fifth column). For desR406W, 643 
spots corresponding to potential proteolysis remained present, potentially with one 644 
additional higher-molecular-weight spot.  645 
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To further analyze our in vivo results, we compared these patterns to protein extracts 646 
from AAV-desWT-injected or AAV-des-D399Y-injected muscles. None of the 647 
modifications observed in cells could be detected in muscle given the high presence 648 
of aggregates and morphological alterations presented above (Figure 7, last two 649 
columns). Indeed, in AAV-desWT-injected as well as AAV-D399Y-injected muscles in 650 
the absence of NAC, four forms of desmin appeared at the expected molecular 651 
weights. After pretreatment with NAC, the profile appeared to be globally identical, 652 
although only three spots seemed to remain, with probable disappearance of the 653 
highest-pI form.  654 
Finally, patterns obtained with muscles or satellite cells from KI-R405W (Figure 7, 655 
last lines) displayed many PTMs around the values in Tables 1 and 2, indicating both 656 
molecular weight and potential known phosphorylation modifications. 657 
Discussion: 658 
Usually, no proline residue is present in the central domain in desmin alpha helices. 659 
This residue is known to create a bend of ~25° in the helix (48). However, with Pymol 660 
software, it is only possible to visualize that the alpha amine of this residue no longer 661 
participates in alpha helix stabilization. Helix 2B length and rigidity may be sufficient 662 
to attenuate this deformation. In the case of replacement of alanine with a proline 663 
(A357P), this position supposedly stabilizes the dimer with ionic interactions. 664 
Substitution of proline at least alters the alpha helix and should be enough to drive 665 
the pathological phenotype. Size and bulkiness of the side chain has a moderate 666 
effect, as shown in Figure 2B, and affects hydrophobicity. Pymol software indicates 667 
that the helix deformation for Q389P comes with a moderate potential change 668 
outside the coiled coil, which can affect interactions between several dimers and may 669 
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impact polymerization. Proline extends less beyond the helix than glutamine, which 670 
may affect assembly of the dimers in tetramer and/or radial compaction. In fact, 671 
Q389P could be compared to other mutations leading to replacement of a residue by 672 
a proline, such as R350P (b in heptad as Q389P), A357P (e in heptad as D399Y), 673 
and L370P (inside the heptad, leading to a lost hydrophobic interaction). However, 674 
R350P is upstream of the stutter, A357P is in the stutter, and L370P creates a bend 675 
in a conserved sequence, similar to Q389P, but at different coiled coil locations. It is 676 
therefore possible that proline destabilization of the alpha helix is not equivalent for 677 
these four positions, even if their pathogenic effect is established (37). On the other 678 
hand, abolishing interactions between side chains [C–O of aspartate (399) or 679 
glutamate (401) with NH of lysine (395) or arginine (406)] may destabilize the dimer. 680 
In addition, tyrosine spreads much more than aspartate and changes the charge at 681 
this position. For tryptophan, its orientation and size are also very different from those 682 
of arginine. These two mutations could also interfere with dimer assembly in the 683 
tetramer and/or with radial compaction. For R406W, modeling has already been used 684 
to study the interactions of desmin and synemin (49), which strengthens the desmin 685 
network. These anchors are not permitted by the mutation, even though the 406 686 
residue is not in charge of the interaction. Again, this indicates that the effect of 687 
substitution on the secondary structure might not be predominant, that side chain 688 
size could disturb tetramer or later assembly, and that accumulation affects 689 
construction of the network, which could have a disturbing influence. However, the 690 
dimeric structure does not allow us to see this cumulative process. 691 
Our inducible cell lines allow comparisons between desmin mutants in an isogenic 692 
environment. The basic properties of the cell lines (proliferation and inducibility) were 693 
similar to cells expressing desWT or desD399Y. In addition, expression levels of the 694 
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exogenous proteins are close to or below a ratio of 1:1 with respect to endogenous 695 
murine desmin, minimizing the effect of overexpression by maintaining closer-to-696 
physiological conditions. These isogenic contexts enable comparisons of only 697 
mutation effects and allow analysis of their behavior in parallel. Random insertion 698 
matter could be bypassed with new gene technologies. However, we tested several 699 
clones for each mutation to ensure that the observed effect is indeed dependent on 700 
mutation and not insertion. Moreover, for R406W mutation, redox effects have been 701 
validated in satellite cells from R405W-KI mice. Additionally, these clones present an 702 
inducible expression that avoid deleterious effects of overexpression. Finally, it would 703 
be interesting to have cells or muscles from patients to confirm these results; 704 
unfortunately, they are extremely rare and no samples are currently available for the 705 
mutations studied. 706 
Currently to detect desmin point mutations, there is only one specific antibody for 707 
R349P. To sense specifically exogenous human desmin, we therefore used a Myc-708 
tag. Indeed, it allows first to quantify (via a shift with desmin antibody) the exogenous 709 
desmin vs endogenous and second to detect specifically the human desmin carrying 710 
the 6 mutations studied. In addition, we have previously shown that the Myc-tag in N-711 
terminal position, does not cause any alteration in the formation of the WT desmin 712 
network in cellulo, with or without environment changes (31). Surprisingly, stress did 713 
not induce similar aggregation patterns for all 2B mutations as it did in cells 714 
expressing the desD399Y mutation. These results suggest that, despite the presence 715 
of proline in the rod domain, desA357P-expressing cells are not so sensitive to 716 
external stress, unlike desQ389P. These results are similar to those for desS46Y and 717 
desS460I, located respectively in the head and tail domains, which were previously 718 
shown to have no stress-induced aggregation (33). Our results here show that 719 
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desQ389P behaves like desD399Y in terms of aggregate shape and formation upon 720 
stress, while desR406W responds to stress to a lesser extent than desQ389P or 721 
desD399Y, indicating desR406W may be more sensitive to environmental changes in 722 
each experiment. Transient experiments show that all mutations have the same 723 
dominant negative effect and lose the ability to form a network without IFs 724 
(16,17,37,50). However, our stable clones reveal specific characteristics for each 725 
mutation in response to stress. This sensitivity to stress cannot be related to the type 726 
of mutation (e.g., proline substitution) or region in the protein (e.g., 2B domain), 727 
confirming the variability of aggregate induction mechanisms.  728 
To decipher the underlying molecular mechanisms, we constructed compartment-729 
specific genetically encoded redox reporters. The cyto-Grx1-roGFP2 reporter did not 730 
reveal any difference of cytoplasmic GSH/GSSG redox state between C2C12 cells 731 
expressing desWT and desD399Y. It is possible that desD399Y expression induces 732 
only a slight change of GSH/GSSG ratio that is beyond detection by cyto-Grx1-733 
roGFP2 reporter. Consistently, we were unable to detect any GSSG in C2C12 cells 734 
and in our clones by high performance liquid chromatography (data not shown). In 735 
contrast, cyto-HyPer reacted differently in cells expressing desWT and in some 736 
desmin mutants to oxidative stress-induced aggregation. A significant shift was 737 
observed at 60 min, with a greater amount of the oxidized probe found in clones 738 
expressing desD399Y and desR406W (Figure 5B). In addition, the delayed return to 739 
a normal redox ratio took up to 120 min, especially for the desD399Y clone. Delayed 740 
oxidation kinetics related to H2O2 metabolism could reflect an imbalanced redox 741 
homeostasis in mutant cells, although no H2O2 increase was detectable at steady-742 
state. Furthermore, satellite cells extracted from KI-R405W mice exhibited similar 743 
results, confirming the implication of redox balance pathways. Finally, observations 744 
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with mito-HyPer reporter imply that it is the cytoplasmic redox homeostasis that is 745 
mostly affected in desmin mutants. 746 
Cytoplasmic redox dynamics in response to oxidative stress varied in various 747 
mutants. Cells expressing desWT and desQ389P could rapidly restore the redox 748 
balance as indicated by HyPer reporter, while cells expressing desD399Y and 749 
desR406W required more recovery time. On the other hand, desQ389P and 750 
desD399Y displayed similar cellular aggregation. Therefore, these mutants may rely 751 
on different altered enzymatic pathways and each mutation may affect specific redox 752 
mechanism.  753 
Finally, NAC pretreatment induced WT-like results in desD399Y and desR406W 754 
cells. As in the case of SEPN1- Knock Out (KO) cells, NAC pretreatment reduces 755 
abnormal sensitivity to oxidative stress induced by H2O2 (30). Cytoplasmic redox 756 
balance related to H2O2 content is therefore weakened in the context of D399Y or 757 
R406W mutation. We have previously shown that, in cells expressing desD399Y, 758 
cadmium chloride (non-oxidative, heavy metal) disturbs the redox dynamic and 759 
induces moderate aggregation (33). Therefore, redox homeostasis seems to be 760 
fragile in these mutant desmin-expressing cells, so reducing treatment can cause 761 
destabilization. This may have deleterious effects on desmin network stability in the 762 
context of mutants and NAC would indirectly reduce this sensitivity through 763 
glutathione synthesis.  764 
Therefore, it may be important for trials of therapeutic molecules to test a wider range 765 
of mutations expressed in murine models. Our laboratory has recently experimented 766 
with a new type of mouse model that is faster to produce than the KI model. We 767 
introduced two desmin mutations (R406W and E413K) into AAV vectors and injected 768 
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11-week-old mouse TA muscles (45). Analysis of these muscles showed 769 
morphological changes and decreased contractile force, as observed in patients with 770 
myofibrillar myopathies. The relatively fast timeline of these experiments suggests an 771 
ability to study several mutations in parallel.  772 
The AAVs used in this study were produced by a platform at the National Institute for 773 
Health and Medical Research in France, which is different from the laboratory that 774 
constructed the desR406W and desE413K viral vectors (45). Differences in 775 
transduction may therefore be due to preparation and technical details as well as the 776 
individual batch. However, since we injected a maximal volume (70 μL) with respect 777 
to muscle size, we could not increase transduction efficiency. So, the variability 778 
associated with limited muscle transduction was quite acceptable for a phenotypic 779 
study of the impact of desmin over-expression. Indeed as in cells, desmin level 780 
remains moderate (Supp. Data 2). Nonetheless, muscle fibers had a very high level 781 
of aggregation, up to 90% in fibers expressing exogenous desD399Y, while only a 782 
few percent in those expressing desWT. Thus, the location of D399Y is disturbed, 783 
similar to patients’ muscles, despite expression in an already mature muscle. 784 
Moreover, as for the cell lines desD399Y, aggregates are located close to the nuclei 785 
like in R406W but not in E413K, shown in a previous study (45). This comparison 786 
also applies to SDH staining. In addition, some fibers with aggregates had lighter 787 
SDH-stained areas, which could be explained by the low number of mitochondria in 788 
this fiber type. In R406W fibers, these non-stained areas are more extensive and 789 
seem to affect all fiber types.  790 
As mouse muscles presented pathophysiological characteristics that mimic some of 791 
those found in human patients, we treated mice with 20 mM NAC, which is the 792 
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commonly used dose for such experiments (49), and higher concentrations seem to 793 
have secondary effects on WT mice (unpublished data from our lab). After 1–2 794 
months of NAC pretreatment fibers showed comparable aggregation with or without 795 
treatment. Furthermore, NAC increased the number of muscle fibers and decreased 796 
their size. Antioxidant supplementation can have a negative impact on acute 797 
exercise, suggesting that adaptation to such stress is more dependent on redox 798 
homeostasis (51). This is consistent with the role of ROS as intracellular signaling 799 
molecules, so the observed hyperplasia may be due to lack of ROS in the presence 800 
of NAC, which can have such an effect even without exercise. 801 
Regarding defects in aggregation prevention, one question is whether the dose of 802 
NAC was appropriate. We do not have internal markers to ensure NAC was delivered 803 
to muscle. However, NAC-treated mice drank less than untreated mice, although no 804 
dehydration was observed (Supp. Data 4). This decreased drinking volume could be 805 
due to the very low pH of NAC solution or the taste of NAC solution. Nonetheless, the 806 
daily NAC dose that mice absorbed remained constant over time. Furthermore, the 807 
NAC quantities absorbed in our study were similar to those in other studies, where 808 
NAC was effective (e.g., KO-SEPN1 mice) (30). Thus, accessibility of NAC to 809 
muscles should have been appropriate in our study.  810 
Another question then arises—why did NAC have no effect in muscle while it 811 
prevents D399Y aggregation in cells? Among several hypotheses, one of the most 812 
probable is that expression of mutant desmin in the muscle sarcoplasm happens too 813 
quickly and/or reaches levels too high for the antioxidant effect to be preventive. 814 
Thus, once aggregation has been established, using antioxidant molecules has no 815 
effect. NAC treatment may therefore be more appropriate as a first step before 816 
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injection, identical to cellular models. However, this experimental course is more 817 
difficult to extrapolate to therapy for patients who have the mutation at birth. 818 
Alternatively, we could test other anti-aggregative molecules, such as PP242 or NCS 819 
23766, or combine the effects of several molecules, as is done in cell lines (34). An 820 
alternative hypothesis is that expression of desD399Y in mature muscles does not 821 
initially affect redox balance but may do so in a secondary manner. In that case, 822 
studies would need to test the effect of NAC treatment for a longer period of time, for 823 
which the KI mouse model could be useful. 824 
Desmin PTMs in both myoblast and muscle contexts were consistent with the 825 
absence of network alterations immediately or a few hours after heat shock or 826 
oxidative stress. These behaviors indicate that stress is not directly related to 827 
aggregation, but that the cellular stress response may be connected to the presence 828 
of mutations on soluble-desmin protein or associated in filaments. These results also 829 
show singular reactions of desmin to adapt to intrinsic alteration with environmental 830 
changes. These changes thus seem to be a post-aggregative process. In fact, 831 
aligned spots of the same molecular weight seem to indicate potential known desmin 832 
phosphorylations, with some additional for stresses exposition. Nowadays, no other 833 
small modifications are described for desmin and it seems here not to participate in 834 
early pathophysiological mechanisms.  So hyper-phosphorylation 24 h after stress 835 
could be one common point. Stress may not depolymerize the desmin network or 836 
alter repolymerization in the mutant context (52). Rather, phosphorylation seems to 837 
drive the depolymerization/repolymerization process preferentially for aggregated 838 
proteins. PTMs with superior weights, seen for desD399Y, could correspond to PTMs 839 
known for desmin or other IFs due to short peptides (i.e., ubiquitination or 840 
sumoylation). This signal addresses peptides to various degradation processes that 841 
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are more complex than proteolysis (ubiquitin proteasome system or autophagy). 842 
Alternatively, Olivé et al. (53) found an aberrant form of ubiquitin, UBB+1, that co-843 
localizes with aggregates in skeletal muscles biopsies of patients with myotilinopathy 844 
or desminopathy. Other IFs, lamins, and keratins are sumoylated or even hyper-845 
sumoylated under pathological conditions (54). Additional studies could provide a link 846 
between these processes in terms of aggregate elimination mechanisms in regards 847 
to mutation location.  848 
In the same way, proteolysis related to calpain and caspases could explain the lower-849 
weight forms of desQ389P and desR406W as it has been shown in meat (55). 850 
Compared with native desmin isolated from bovine muscle, degradation of oxidized 851 
desmin is enhanced by caspases but suppressed by μ-calpain (55). This study also 852 
used circular dichroism spectra of desmin to show that oxidation modifies desmin’s 853 
secondary structure—α-helix content decreased from 76.2% to 52.0%, while random 854 
coil content increased from 8.0% to 22.4%.  855 
We did not detect any extra-PTMs in cells or injected muscles, similar to results 856 
described for patient muscles (31,32,56). One hypothesis is that no additional PTMs 857 
occur, even in desmin aggregates. Indeed, desmin overexpression might overload 858 
enzymes and prevent further PTMs. Another hypothesis is that muscle response is 859 
delayed and thus may occur at a later timepoint than our observations. However, 860 
supplementary PTMs are present in KI-R405W mouse muscles and even untreated 861 
satellite cells, suggesting an early effect on desmin PTMs patterns, similar to 862 
phosphorylations. Nonetheless, this could be due to an early alteration of redox 863 
balance in the homozygous KI context, as has been suggested for linked ROS and 864 
PTMs in muscle exercise (57).  865 
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 866 
Conclusion  867 
Our study demonstrates that redox balance can be altered by expression of at least 868 
some desmin mutants. Our results highlight that each mutation has unique 869 
pathological molecular mechanisms such as maintaining redox balance and/or 870 
protein regulation and aggregation. Therefore, it will be important to integrate these 871 
specific behaviors when considering future therapeutics. 872 
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Supporting Information 1066 
 1067 
Supp. Data 1: Box plot representing the aggregation percentages 24 h after stress (T24) compared to 1068 
untreated cells. Three different treatments are shown: heat shock (HS), oxidative stress (H2O2), and 1069 
no stress (NT). Cells were counted in at least 3 independent experiments (>100 cells each) (ns: not 1070 
significant; *p < 0.05, compared to unstressed). 1071 
1072 
 49 
 
 1073 
 1074 
 1075 
 1076 
Supp. Data 2: Desmin expression levels in AAV-infected muscles. Representative Western blot 1077 
analysis of endogenous and human Myc-desmin in muscles injected with AAV expressing WT or 1078 
D399Y (Mut) desmin. Actin serves as a loading control. 1079 
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 1080 
Supp. Data 3: Effect of NAC on fiber number and median fiber diameter in TA muscles 1081 
expressing ectopic human desmin. (A) Quantification of number of fibers in TA muscles expressing 1082 
WT or D399Y mutant desmin, untreated or treated with NAC. Plot shows the average of the total 1083 
number of fibers in 4 sections from 4 injected muscles for each condition (n.s.: p > 0.05; **: p < 0.01). 1084 
(B) Quantification of median fiber diameters (min. Feret values) in TA muscles expressing WT or 1085 
D399Y mutant desmin, untreated or treated with NAC. Diameters were measured on whole muscle 1086 
transversal sections stained with laminin. Medians were calculated with 5 sections from 3 injected 1087 
muscles for each condition (§§§: p < 0.001, each construct compared to others). 1088 
1089 
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 1090 
 1091 
Treatment 
Mean 
volume 
drank 
(mL/day) 
Ratio volume 
drank (without 
NAC/with NAC) 
Mean absorbed 
NAC 
(mg/mouse/day) 
Mean 
absorbed 
NAC 
(g/kg/day) 
Without NAC  
1 month 4.53 1.3 – – 
With NAC          
1 month 3.45 – 11.5 0.38 
Without NAC   
2 months 5.68 1.9 – – 
With NAC         
2 months 2.97 – 10 0.33 
Supp. Data 4: Measures of amount drank by mice. Amount of liquid (water or NAC solution) drank 1092 
by mice after 1 or 2 months. Each group contains an equivalent number of animals injected with AAV 1093 
expressing WT or D399Y mutant desmin. 1094 
